FDA Adverse Event Malfunction Summary report: N

I-STAT CHEM8+ CARTRIDGE

MDR report key: 21160283 · Received January 15, 2025

Report

Report Number
2245578-2025-00004
Event Type
Malfunction
Date Received
January 15, 2025
Date of Event
December 7, 2024
Report Date
February 26, 2025
Manufacturer
ABBOTT POINT OF CARE
Product Code
JPI
PMA / PMN Number
K183680
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

APOC INCIDENT # (B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.

Additional Manufacturer Narrative · 0

APOC INCIDENT: # (B)(4). THE INVESTIGATION WAS COMPLETED ON 20-FEB-2025. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) CONFIRMED THE CARTRIDGE LOT MET FINISHED GOODS (FG) RELEASE CRITERIA. RETAINED CARTRIDGE TESTING MET THE ACCEPTANCE CRITERIA OUTLINED IN APPENDIX 1 OF Q04.01.003 REV. AN, PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE. NO DEFICIENCY HAS BEEN IDENTIFIED FOR CHEM8+ CARTRIDGE LOT H24291A.

Description of Event or Problem · 0

ON (B)(6) 2024, ABBOTT POINT OF CARE WAS CONTACTED BY A CUSTOMER REGARDING I-STAT CHEM8+ CARTRIDGE THAT YIELDED DISCREPANT CREATININE RESULTS ON A FEMALE PATIENT. THERE WAS NO ADDITIONAL INFORMATION AT THE TIME OF THIS REPORT. METHOD : DATE : COLLECTED TESTED: RESULTS : SAMPLE: I-STAT, ON (B)(6)2024, 11:19 , 11:20 , 2.1 MG/DL, A: WB. LAB , ON (B)(6) 2024, 11:19 NI , 0.71 , A: SERUM. I-STAT ,ON (B)(6) 2024 , 10:48 10:48 , 2.1 MG/DL, B: WB. LAB , ON (B)(6)2024, 10:48 NI , 0.75 , B: SERUM. AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. THE REPORTING DECISION WAS BASED ON THE LIMITED INFORMATION AVAILABLE THAT SUGGESTED THAT PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY. THE INVESTIGATION IS UNDERWAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1584187 I-STAT CHEM8+ CARTRIDGE CHEM8+ CARTRIDGE JPI ABBOTT POINT OF CARE NA

Patients

Seq Age Sex Outcome Treatment
1 NA Female